Adero Partners LLC Has $922,000 Stock Holdings in The Procter & Gamble Company (NYSE:PG)

Adero Partners LLC increased its stake in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 5.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,322 shares of the company’s stock after purchasing an additional 289 shares during the quarter. Adero Partners LLC’s holdings in Procter & Gamble were worth $922,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Acorn Creek Capital LLC increased its position in Procter & Gamble by 2.8% in the 3rd quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company’s stock valued at $376,000 after acquiring an additional 59 shares during the period. Patrick M Sweeney & Associates Inc. increased its position in Procter & Gamble by 1.1% in the 3rd quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company’s stock valued at $963,000 after acquiring an additional 59 shares during the period. Hudson Value Partners LLC increased its position in Procter & Gamble by 4.1% in the 2nd quarter. Hudson Value Partners LLC now owns 1,516 shares of the company’s stock valued at $250,000 after acquiring an additional 60 shares during the period. Traveka Wealth LLC increased its position in Procter & Gamble by 1.7% in the 3rd quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock valued at $616,000 after acquiring an additional 60 shares during the period. Finally, Fiduciary Alliance LLC increased its position in Procter & Gamble by 2.8% in the 2nd quarter. Fiduciary Alliance LLC now owns 2,261 shares of the company’s stock valued at $371,000 after acquiring an additional 61 shares during the period. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, CEO Jon R. Moeller sold 31,797 shares of the company’s stock in a transaction dated Tuesday, August 20th. The shares were sold at an average price of $169.22, for a total value of $5,380,688.34. Following the sale, the chief executive officer now directly owns 300,777 shares of the company’s stock, valued at $50,897,483.94. This represents a 9.56 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Balaji Purushothaman sold 12,800 shares of the company’s stock in a transaction dated Thursday, October 24th. The stock was sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the completion of the sale, the insider now directly owns 11,566 shares in the company, valued at $1,954,538.34. This represents a 52.53 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 313,597 shares of company stock worth $53,268,499. 0.18% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several equities analysts have issued reports on PG shares. Royal Bank of Canada restated a “sector perform” rating and issued a $164.00 price target on shares of Procter & Gamble in a research report on Monday, October 21st. Hsbc Global Res raised shares of Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. JPMorgan Chase & Co. upped their price objective on shares of Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research note on Thursday, September 19th. StockNews.com lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Finally, DA Davidson upped their price objective on shares of Procter & Gamble from $159.00 to $160.00 and gave the company a “neutral” rating in a research note on Monday, October 21st. Nine investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $177.00.

View Our Latest Research Report on Procter & Gamble

Procter & Gamble Trading Up 1.5 %

NYSE:PG opened at $169.54 on Friday. The company has a fifty day moving average of $170.32 and a 200 day moving average of $168.36. The Procter & Gamble Company has a 52 week low of $142.50 and a 52 week high of $177.94. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The firm has a market capitalization of $399.27 billion, a P/E ratio of 29.23, a P/E/G ratio of 3.67 and a beta of 0.42.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings data on Friday, October 18th. The company reported $1.93 EPS for the quarter, topping the consensus estimate of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The business had revenue of $21.74 billion during the quarter, compared to analyst estimates of $21.99 billion. During the same period in the prior year, the business earned $1.83 EPS. The company’s revenue for the quarter was down .6% on a year-over-year basis. On average, research analysts predict that The Procter & Gamble Company will post 6.94 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were issued a $1.0065 dividend. The ex-dividend date was Friday, October 18th. This represents a $4.03 annualized dividend and a yield of 2.37%. Procter & Gamble’s dividend payout ratio (DPR) is presently 69.48%.

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Featured Articles

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.